Merryspring Medical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Merryspring Medical - overview
Established
2022
Location
Jiaxing, Zhejiang, China
Primary Industry
Medical Devices & Equipment
About
Founded in 2022 and based in Jiaxing, China, Ronghe Medical Technology (Zhejiang) Co. , Ltd. develops medical devices that apply energy-based ablation technologies for respiratory diseases and oncology. The company focuses on device platforms that integrate electromagnetic navigation and non-thermal ablation mechanisms to support minimally invasive interventions.
In November 2025, the company closed a round of series B funding led by Qiming Venture Partners. The company works with hospitals and clinical research institutions to provide energy-based ablation platforms such as the "Breeze One" electromagnetic-navigation pulsed-field ablation system. Its solutions support targeted airway intervention, real-time guidance and automated ablation mapping for COPD and other respiratory disease management. The company generates revenue through direct sales of medical devices to hospitals and clinical partners.
The company plans to expand clinical adoption of its COPD intervention system, pursue additional domestic and international regulatory approvals and advance global commercialization of its respiratory ablation product line.
Current Investors
Qiming Venture Partners, Lotus Lake Capital, ChuangVest Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Oncology/Cancer Treatment, Medical Devices & Equipment, Web Applications
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.